Iterum Therapeutics plc (ITRMF)

Iterum Therapeutics Revenue

Iterum Therapeutics had revenue of $390.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $390.00K.

• Revenue (ttm): 390.00K
• Revenue Growth: n/a
• P/S Ratio: 6.10
• Revenue / Employee: 43.33K
• Employees: 9
• Market Cap: 2.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 19, 2026

Data Sources Report a data error